|
|
|
| top>>News>>Information |
|
 |
Information |
|
|
|
|
|
*March 16 - 18, 2009
Exhibit at SOT2009, Annual Meeting and ToxExpo in Baltimore, MD, USA.
*December 18, 2008
New addition to TOX-LAUNCHER line : Clinical Observation Subsystem.
*September 19, 2008
RaQualia Pharma Inc. has become a TOX-LAUNCHER user.
*April 15, 2008
Received investment of 48 million yen.
Press Release(pdf)
Press Release(html)
*March 17-19, 2008
Exhibit at SOT2008, Annual Meeting and ToxExpo in Seattle, WA, USA.
*January 21, 2008
KANEKA Corporation chooses TOX-LAUNCHER.
Press Release(pdf)
Press Release(html)
*January , 2008
Opened Tokyo liaison office.
*December 26, 2007
H & T receives investment of 20 million yen.
click here to see Press Release
*November 26, 2007
H & T receives combined investment of 100.5 million yen.
Press Release(pdf)
Press Release(html)
*October 31, 2007
New addition to TOX-LAUNCHER line : Clinical Pathology Subsystem.
Press Release(pdf)
Press Release(html)
*August 8, 2007
Meiji Seika Kaisha has become the newest user of TOX-LAUNCHER.
click here to see Press Release
*June 27-29, 2007
Exhibit at The 34th Annual Meeting of The Japanese Society of Toxicology Held in Tokyo.
Held the 3rd H & T Users’ Meeting during the meeting period.
*March 2007
Exhibit at SOT2007, Annual Meeting and ToxExpo in Charlotte, North Carolona,USA.
An illustrated report of our results during the convention can be seen here:
http://www.ht21.co.jp/english/erelease/SOT2007.html
*December 2006
Recognized by the ‘Business Innovation Challenge Support Project for Small Businesses 2006’ of the Mie Industry Enterprise Support Center.
*November 2006
Exhibit at the 19th HigashiOsaka Industrial Fair, Techno Messe HigashiOsaka 2006.
*August 4, 2006
Recognized by the ‘Intellectual Property Strategy Support Project for Small Business 2006’ of the Mie Industry Enterprise Support Center.
*July 3-5, 2006
Exhibit at The 33rd Annual Meeting of The Japanese Society of Toxicology Held The 2nd H & T Users’ Meeting during the meeting period.
Dr. Toshiaki Matsuzawa of the Mario Labs. gave the lecture:
"ER/ES Regulations in terms of GLP studies/ Preparation for 21 CFR Part11"
*July 3-5, 2006
Japanese Society of Toxicology in Nagoya,Japan.
*June 18-22, 2006
25th Society of Toxicologic Pathology in Vancouver, Canada.
*March 15-16, 2006
Exhibit at The International Symposium- “Threshold of carciogenicity and genotoxicity”in Kobe, Japan.
*March 2006
Establishment of Tokyo office (Kanagawa Pref.)
*February 2006
President Hamada gives lecture at Mie Pref. Venture Seminar.
*January 26-27,2006
Exhibit at The 22nd Japanese Society of Toxicologic Pathology in Kagoshima, Japan.
*January 19, 2006
President Hamada gives lecture at Nagoya University.
*December 2005
Invested by Mie New Industry Creation Venture Capital Investment Limited Partnership Capital increased to 90.75 Million Yen ⇒ HT Press Release
*July 21, 2005
Entry of a bid for a public tender to the Mie Prefecture Capital increased to $ 570 thousand.
*June 29-July 1, 2005
Held an exhibit at The 32nd Annual Meeting of the Japanese Society of Toxicology
*June 19-22, 2005
Attended BIO 2005 Annual International Convention in Philadelphia
*June 18, 2005
Attended 6th Annual Philadelphia-Japan Health Science Dialogue" International Expansion Across the Ocean:The Business Case for Doing It Alone VS Partnering".
*April 26, 2005
H&T was introduced by The Higashiosaka Chamber of Commerce and Industry on export-japan.com, inc.
*April 11, 2005
Presentation at the seminar under the auspice of R&D Foundation of Drug Evaluation of Japan Pharmaceutical Manufactures Association (JPMA).
H&T's Topic: The New FDA Submission Format "SEND" and the Current Computer Software compliance with GLP and FDA 21 CFR Part 11.
*March 6-10, 2005
Held an exhibit at Society of Toxicology ( Tox Expo 2005)
in New Orleans.
Click here to see the pictures from the Tox Expo 2005.
*March , 2005
Opened the liaison office inside Science Center in Philadelphia.
*February , 2005
Opened Shikoku liaison office.
*January 19-21, 2005
Exhibit at The 21st Japanese Society of Toxicologic Pathology Held The 1st H & T Users’ Meeting at Hamamatsu, Shizuoka Pref.
*December , 2004
Installation of "TOX-LAUNCHER" to the TAIHO Pharmaceutical Co.,Ltd..
*December 7, 2004
MAVC 2004 uploaded H&T's presentation on their website, given on October 26, 2004 International Track.
Click here to see the pictures from the MAVC 2004
*October 25, 2004
Attended MAVC(Mid-Atlantic Venture Conference)2004 as the Featured Company. Presented our business plans at Pennsylvania Convention Center.
*September 20, 2004
Attended the MAVC2004 Featured Company Boot Camp
H&T was introduced on the newsletter; IP links as MAVC Presenting Company
*July 6-8, 2004
Held an exhibit at The 31th Japanese Society of Toxicology in Osaka, Japan.
*July, 2004
H & T was introduced by JETRO for the participation in JETRO's International Internship Program business.
*May 3-5, 2004
Attended the IVT "Computer Systems and Software Validation" Forum in Washington D.C.
*Early April, 2004
Installation of "TOX-LAUNCHER" to the Mitsubishi Pharma Corporation.
]
*April 1, 2004
Tokai business office established.
Tokai contact office changed to Tokai business office (Kuwana City, Mie Prefecture).
*March 21, 2004
Held an exhibit at Society of Toxicology (Tox Expo 2004), in Baltimore, Maryland, USA.
*November 12-14, 2003
Held an exhibit at ICH 6
*September 1, 2003
Opened new web page redesign
*July 19-20, 2003
Exhibited at The 30th Congress of Japanese Society of Toxicology at Azabu University 100 anniversary memorial hall
*July 16, 2003
Endorsed by the Japanese Kansai Bureau of Economy, Trade, and Industry with Subsidies for Creative Technology R&D (2003)
*May 30, 2003
Welcomed an international internship student from Pittsburgh University, United States. with the support of JETRO (Japan External Trade Organization) International Internship Business. She will be working with us for 1 year.
*February 26, 2003
Capital increased to 47 million yen
*January 23-24, 2003
Exhibited at The 19th Congress of Japanese Society of Toxicology Pathology
*January, 2003
Accepted an additional order for "the TOX-LAUNCHER remote respondent test" from Eisai Corporation
Accredited with the "Venture Business Finance Supporting Act" by FORECS (Foundation for Osaka Research Enterprise Companies), Osaka's Industrial Promotion Organization
|
|
|
|
|
|
